NCT07467161Not yet recruiting
Relationship Between Insulin Resistance and Vitamin D in Type 2 Diabetes Mellitus (DM)
Impact of Vitamin D Deficiency on Insulin Resistance Assessed by Triglyceride Glucose Index in Type 2 Diabetic Patients
Source: ClinicalTrials.gov · Last updated 13 Mar 2026
Brief summary (registry, in English)
The primary aim of the study is to evaluate the association between vitamin D levels and triglyceride-glucose index as a marker of insulin resistance in patients with type 2 DM.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 165 (estimated)
- First submitted
- 8 Mar 2026
- Start date
- 1 Mar 2026
- Primary completion date
- 31 Jan 2028
- Lead sponsor
- Assiut University
- Diseases
- Type 2 diabetes
- NCT number
- NCT07467161
What you commit to
- Study type: Observational
- Planned participants: 165
- From 1 Mar 2026 to the primary completion date, 31 Jan 2028
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients on lipid lowering therapy.
Other illness
- Patients with type 1 DM or other types of diabetes.
- Malignancy.
- Major co-morbidities as end-stage renal disease or liver cell failure.
Other
- Patients with complications of acute DM.
- Pregnant females.
- BMI \> 35 kg/m²
- Patients on vitamin D supplementation.
Who the study is looking for
- Patients with type 2 DM diagnosed based on American Diabetes Association criteria.
Sex: All
This page is information, not medical advice. Discuss any trial with your doctor.